Cancer Diagnostics Market worth $26.6 billion by 2026
The report “Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) – Global Forecasts to 2026″ The global cancer diagnostics market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion...
Analyzing the Global Cancer Diagnostics Market: Growth, Challenges, and Opportunities
The global cancer diagnostics market in terms of revenue was estimated to be worth $17.2 billion in 2021 and is poised to reach $26.6 billion by 2026, growing at a CAGR of 11.5% from 2021 to 2026.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121
Key Market Players:The major players in the cancer diagnostics market are Danaher Corporation...
In-depth Analysis of the COVID-19 Impact on Global Cancer Diagnostics Market 2021
According to the new market research report “Cancer Diagnostics Marketby Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) – Global Forecasts to 2026″, published by MarketsandMarkets™, is projected to reach USD 26.6 billion by...
Cancer Diagnostics Market – Size, Share, Trends| Global Forecast
The Global Cancer Diagnostics Market is expected to reach $13.1 Billion, at a CAGR of 12.9%
Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing number of cancer cases, the rapid rise in geriatric population, awareness initiatives by governments, and increasing government funding are major factors driving the Cancer Diagnostics Market growth.
However,...